scholarly article | Q13442814 |
P356 | DOI | 10.2337/DIABETES.54.11.3154 |
P8608 | Fatcat ID | release_zmlexwoaubaspidhc54kxzz56e |
P698 | PubMed publication ID | 16249439 |
P5875 | ResearchGate publication ID | 7518086 |
P2093 | author name string | Clinton R Bruce | |
George J F Heigenhauser | |||
David J Dyck | |||
Valerie A Mertz | |||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | obesity | Q12174 |
Glucose | Q37525 | ||
fatty acid | Q61476 | ||
P1104 | number of pages | 7 | |
P304 | page(s) | 3154-3160 | |
P577 | publication date | 2005-11-01 | |
P1433 | published in | Diabetes | Q895262 |
P1476 | title | The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects | |
P478 | volume | 54 |
Q37864217 | AMP-activated protein kinase and metabolic control |
Q37135564 | AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin |
Q44346911 | Activation of κ-opioid receptor exerts the glucose-homeostatic effect in streptozotocin-induced diabetic mice |
Q33896080 | Acylated and unacylated ghrelin do not directly stimulate glucose transport in isolated rodent skeletal muscle. |
Q46837274 | Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells. |
Q37486025 | Adipokines as regulators of muscle metabolism and insulin sensitivity |
Q38784887 | Adipokines in Healthy Skeletal Muscle and Metabolic Disease |
Q36537039 | Adiponectin and risk of vascular events in the Northern Manhattan study |
Q38932521 | Adiponectin attenuates Ang Ⅱ-induced TGFβ1 production in human mesangial cells via an AMPK-dependent pathway |
Q46662601 | Adiponectin concentration is associated with muscle insulin sensitivity, AMPK phosphorylation, and ceramide content in skeletal muscles of men but not women. |
Q35219362 | Adiponectin in cardiovascular inflammation and obesity |
Q48245764 | Adiponectin inhibits inflammatory cytokines production by Beclin-1 phosphorylation and Bcl-2 mRNA destabilization: Role for autophagy induction. |
Q37653646 | Adiponectin inhibits tumor necrosis factor-α-induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation |
Q41848888 | Adiponectin is not required for exercise training-induced improvements in glucose and insulin tolerance in mice |
Q50475289 | Adiponectin is sufficient, but not required, for exercise-induced increases in the expression of skeletal muscle mitochondrial enzymes. |
Q33577630 | Adiponectin resistance and vascular dysfunction in the hyperlipidemic state |
Q46202689 | Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats |
Q28573186 | Adiponectin stimulates phosphorylation of AMP-activated protein kinase alpha in renal glomeruli |
Q50957771 | Adiponectin-Resistance in Obesity. |
Q33960181 | Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques. |
Q38054603 | Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure |
Q30409518 | Altered body composition and energy expenditure but normal glucose tolerance among humans with a long-chain fatty acid oxidation disorder. |
Q37112535 | Antioxidant supplemention in the treatment of skeletal muscle insulin resistance: potential mechanisms and clinical relevance |
Q99708919 | Are Alterations in Skeletal Muscle Mitochondria a Cause or Consequence of Insulin Resistance? |
Q37176719 | Beneficial effects of combined resveratrol and metformin therapy in treating diet-induced insulin resistance |
Q80984953 | Brain neuropeptide Y and CCK and peripheral adipokine receptors: temporal response in obesity induced by palatable diet |
Q45010672 | Brain-derived neurotrophic factor and substrate utilization following acute aerobic exercise in obese individuals. |
Q37298116 | Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action |
Q38687619 | Cardiovascular Adiponectin Resistance: The Critical Role of Adiponectin Receptor Modification. |
Q50529797 | Chronic liquid nutrition intake induces obesity and considerable but reversible metabolic alterations in Wistar rats. |
Q40590809 | Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity |
Q33526750 | Compensatory increases in nuclear PGC1alpha protein are primarily associated with subsarcolemmal mitochondrial adaptations in ZDF rats |
Q28570944 | Control of glycogen synthase through ADIPOR1-AMPK pathway in renal distal tubules of normal and diabetic rats |
Q38313076 | Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin. |
Q59810003 | Critical role of tristetraprolin and AU-rich element RNA-binding protein 1 in the suppression of cancer cell growth by globular adiponectin |
Q34615504 | Differential expression of novel adiponectin receptor-1 transcripts in skeletal muscle of subjects with normal glucose tolerance and type 2 diabetes |
Q46178402 | Disturbed adiponectin – AMPK system in skeletal muscle of patients with metabolic syndrome. |
Q36697388 | Duration of rise in free fatty acids determines salicylate's effect on hepatic insulin sensitivity |
Q36825618 | Environmental influences on adiponectin levels in humans |
Q34502156 | Exercise training reverses impaired skeletal muscle metabolism induced by artificial selection for low aerobic capacity. |
Q54540132 | Fish oil prevents high-saturated fat diet-induced impairments in adiponectin and insulin response in rodent soleus muscle. |
Q37855653 | Functional adiponectin resistance and exercise intolerance in heart failure. |
Q64068031 | Ghrelin stimulates fatty acid oxidation and inhibits lipolysis in isolated muscle from male rats |
Q30279123 | Globular adiponectin ameliorates metabolic insulin resistance via AMPK-mediated restoration of microvascular insulin responses |
Q42170113 | Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats |
Q46491807 | Globular adiponectin stimulates glucose transport in type 2 diabetic muscle |
Q34055122 | Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions |
Q33482846 | Hypothalamic neuroendocrine circuitry is programmed by maternal obesity: interaction with postnatal nutritional environment |
Q35001860 | Impaired muscle AMPK activation in the metabolic syndrome may attenuate improved insulin action after exercise training |
Q35906100 | JNK1 deficiency does not enhance muscle glucose metabolism in lean mice |
Q51686950 | Metabolic and behavioral responses to high-fat feeding in mice selectively bred for high wheel-running activity. |
Q35063267 | Metabolic remodeling of human skeletal myocytes by cocultured adipocytes depends on the lipolytic state of the system. |
Q37486050 | Mitochondrial function and dysfunction in exercise and insulin resistance |
Q36419531 | Modulation of Lupus Phenotype by Adiponectin Deficiency in Autoimmune Mouse Models |
Q57587385 | Muscle ceramide content is similar after 3 weeks’ consumption of fat or carbohydrate diet in a crossover design in patients with type 2 diabetes |
Q37618124 | Muscle-specific overexpression of AdipoR1 or AdipoR2 gives rise to common and discrete local effects whilst AdipoR2 promotes additional systemic effects |
Q30423827 | Overexpression of the adiponectin receptor AdipoR1 in rat skeletal muscle amplifies local insulin sensitivity |
Q21328702 | PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer |
Q46729875 | Palmitate acutely induces insulin resistance in isolated muscle from obese but not lean humans |
Q38111707 | Pathophysiology of the diabetic kidney. |
Q52348579 | Plasma adiponectin levels are correlated with body composition, metabolic profiles, and mitochondrial markers in individuals with chronic spinal cord injury. |
Q34533290 | Rapid loss of adiponectin-stimulated fatty acid oxidation in skeletal muscle of rats fed a high fat diet is not due to altered muscle redox state |
Q35173617 | Reduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms. |
Q43504116 | Reduced high-molecular-weight adiponectin is an independent risk factor for cardiovascular lesions in hypercholesterolaemic patients |
Q33998524 | Reduced vascular responsiveness to adiponectin in hyperlipidemic rats--mechanisms and significance |
Q48308518 | Sex differences in the regulation of porcine coronary artery tone by perivascular adipose tissue: a role of adiponectin? |
Q43016757 | Skeletal muscle inflammation is not responsible for the rapid impairment in adiponectin response with high-fat feeding in rats |
Q35173604 | Systemic adiponectin malfunction as a risk factor for cardiovascular disease |
Q37180980 | Targeting the AMPK pathway for the treatment of Type 2 diabetes |
Q37637480 | The Obesity-Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients. |
Q35043710 | The adaptor protein APPL1 increases glycogen accumulation in rat skeletal muscle through activation of the PI3-kinase signalling pathway |
Q36484662 | Thiazolidinediones: effects on insulin resistance and the cardiovascular system |
Q33840362 | Toll-like receptor 4 modulates skeletal muscle substrate metabolism |
Q35576565 | Utilization of dietary glucose in the metabolic syndrome |
Q43139406 | What can adiponectin say about left ventricular function? |
Search more.